Examples of using Reference standard in English and their translations into Bulgarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Items Reference Standard.
The IR spectrum of sample should be identical with that of reference standard; Complies.
Reference standard of Chemical composition.
Production standard reference standard.
Reference standard for chemical composition.
Where O is the observed sensor value andI is the ideal sensor value(i.e., the reference standard).
Reference standard of mechanical properties.
Sample spectrum exhibits maximum only at the same wavelength as that of a similar preparation of the reference standard.
A reference standard, relevant and specific for the active substance and/or the finished product, shall be documented and characterised.
For breath test analysis the individual balancing of the carbon dioxide of the sample to a reference standard gas is essential.
The Zener diode reference standard is the basis for most commercial voltage measuring instruments, voltage standards, and voltage calibrators.
For breath test analysis the individual balancing of the carbon dioxide of the sample to a reference standard gas is essential.
Potency of tenecteplase is expressed in units(U)by using a reference standard which is specific for tenecteplase and is not comparable with units used for other thrombolytic agents.
Principle: trehalose is identified by liquid chromatography and quantified by comparison to a reference standard containing standard trehalose.
To calculate RMSE,we square each error(the deviation from the reference standard), then calculate the arithmetic average of those values, and finally, take the square root of the average.
For modified long-acting factor products it is known that the one-stage clotting assay results are highly dependent on the aPTT reagent and reference standard used.
W-CGMs are prepared individually according to the reference standard ISO 6142, but the calibration procedures are less stringent than those used for the production of G-CGMs and, consequently, their uncertainty is higher.
The MAH presented and discussed the description and composition of the drug product, the pharmaceutical development, the manufacture, control of excipients,the control of drug products, the reference standard, the container closure system and the stability.
The reference standard therefore must be verified as accurate at given intervals, and the calibration must be traceable back to national standards held by the National Physical Laboratory or NPL.
When using an in vitro thromboplastin time(aPTT)-based one stage clotting assay for determining factor IX activity in patients' blood samples,plasma factor IX activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay.
For each of the three drug substance manufacturers(the two separate manufacturer for piperacillin and the tazobactam manufacturer), the MAH presented and discussed general information, the manufacture,the control of drug substance, the reference standard or materials, the container closure system and the stability.
When using an in vitro thromboplastin time(aPTT)-based one stage clotting assay for determining factor IX activity in patients' blood samples,plasma factor IX activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay.
When using an in vitro activated partial thromboplastin time(aPTT)-based one stage clotting assay for determining factor VIII activity in patients' blood samples,plasma factor VIII activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay, which can result in over- or under-estimation of factor VIII activity.
When using an in vitro thromboplastin time(aPTT)-based one stage clotting assay for determining factor VIII activity in patients' blood samples,plasma factor VIII activity results can be significantly affected by both the type of the aPTT reagent and the reference standard used in the assay.
When using an in vitro thromboplastin time(aPTT)-based one stage clotting assay for determining factor VIII activity in patients' blood samples,plasma factor VIII activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay.
When using an in vitro thromboplastin time(aPTT)-based one stage clotting assay for determining factor IX activity in patients' blood samples,plasma factor IX activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay.
When using an in vitro thromboplastin time(aPTT)-based one-stage clotting assay for determining factor VIII activity in patients' blood samples,plasma factor VIII activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay.
When anti-B serum is mixed on a slide with an equal volume of a suspension of B cells with a volume fraction of 0,05 to 0,1, agglutination should first appear in not more than twice the time taken when the same test is performed with the reconstituted butundiluted International Standard Preparation of anti-B blood-grouping serum or with reference standard of equivalent avidity.
When anti-B serum is mixed on a slide with an equal volume of a suspension of B cells with a volume fraction of 0,05 to 0,1, agglutination shall first appear in not more than twice the time taken when the same test is performed with the reconstituted butundiluted International Standard Preparation of anti-B blood-grouping serum or with a reference standard of equivalent avidity.
When anti-A reagent is mixed on a slide with an equal volume of a suspension of A1, A2 and A2B cells with a volume fraction of 0,05 to 0,1, agglutination of each suspension shall first appear in not more than twice the time taken when the same test is performed with the reconstituted butundiluted International Standard Preparation of anti-A blood-grouping serum or with a reference standard of equivalent avidity.